Save the Date

2nd Annual STO-CSCO Joint Symposium

Harnessing Big Data for Precision Medicine
September 23, 2016, Xiamen International Conference and Exhibition Center
Xiamen, China

Translated Articles

《肿瘤学家》精选论文
Read translations of selected articles targeting practice issues relevant to Chinese clinicians.

The Oncologist in China

《肿瘤学家》中国项目概览
Download a 2-page pdf overview of The Oncologist’s Clinical Trial Results section information.

Video Library

视频库
Watch the latest presentations from the STO First Advisory Council: LUNG CANCER: A Grand Challenge for Public Health & Education.

Welcome to 'The Oncologist' in China

Recent Articles from The Oncologist


Clinical Trials | Breast Cancer | Gastrointestinal Cancer | Global Health Cancer | Hepatobiliary | Lung Cancer

Clinical Trial Results

组蛋白去乙酰化酶抑制剂帕比司他治疗低级别神经内分泌瘤的II期临床试验
A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors
Ning Jin, Sam J. Lubner, Daniel L. Mulkerin, Saurabh Rajguru, Lakeesha Carmichael, Herb Chen, Kyle D. Holen, Noelle K. LoConte
The Oncologist 2016; 21:785-786; first published on June 3, 2016; doi:10.1634/theoncologist.2016-0060

磷脂酰肌醇3激酶(PI3K)和哺乳动物雷帕霉素靶蛋白(mTOR)双重抑制剂BEZ235治疗晚期肾细胞癌患者的Ib期研究
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma
Maria I. Carlo, Ana M. Molina, Yulia Lakhman, Sujata Patil, Kaitlin Woo, John DeLuca, Chung-Han Lee, James J. Hsieh, Darren R. Feldman, Robert J. Motzer, Martin H. Voss
The Oncologist 2016; 21:787-788; first published on June 10, 2016; doi:10.1634/theoncologist.2016-0145

来那度胺和索拉非尼用于晚期肝细胞癌患者的I期研究
Phase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Safi Shahda, Patrick J. Loehrer, Romnee S. Clark, A. John Spittler, Sandra K. Althouse, E. Gabriella Chiorean
The Oncologist 2016; 21:664-665; first published on June 2, 2016; doi:10.1634/theoncologist.2016-0071

催乳素受体拮抗剂LFA102用于转移性乳腺癌和去势抵抗性前列腺癌的I期研究
Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer
Neeraj Agarwal, Jean-Pascal Machiels, Cristina Suárez, Nancy Lewis, Michaela Higgins, Kari Wisinski, Ahmad Awada, Michela Maur, Mark Stein, Andy Hwang, Rebecca Mosher, Ernesto Wasserman, Gang Wu, Hefei Zhang, Renata Zieba, Mohamed Elmeliegy
The Oncologist 2016; 21:535-536; first published on April 18, 2016; doi:10.1634/theoncologist.2015-0502

顺铂/替加氟/尿嘧啶/伊立替康三联方案用于治疗复发性/转移性头颈鳞状细胞癌:I/II期临床研究
Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical Study
San-Chi Chen, Peter Mu-Hsin Chang, Muh-Hwa Yang
The Oncologist 2016; 21:537-538; first published on April 18, 2016; doi:10.1634/theoncologist.2015-0515

II期研究中接受雷莫芦单抗治疗的晚期实体瘤患者的校正QT间期心电图特征
Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors
Anthony J. Olszanski, David C. Smith, Luis H. Camacho, John Thompson, Suresh S. Ramalingam, R. Donald Harvey, Luis Campos, David Ferry, Shande Tang, Ling Gao, Howard Safran
The Oncologist 2016; 21:402-403; first published on March 16, 2016; doi:10.1634/theoncologist.2015-0467

在大型肿瘤年会投稿的临床试验摘要的最终发表情况评估
Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting
Paul R. Massey, Ruibin Wang, Vinay Prasad, Susan E. Bates, Tito Fojo
The Oncologist 2016; 21:261-268; first published on February 17, 2016; doi:10.1634/theoncologist.2015-0516

在仅有肝脏转移的转移性KRAS野生型结直肠癌患者中给予FOLFOXIRI联合帕尼单抗治疗后评价切除术情况的II期研究
A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
Johanna C. Bendell, Ahmed Zakari, James D. Peyton, Ralph Boccia, Mark Moskowitz, Victor Gian, Andrew Lipman, David Waterhouse, Richard LoCicero, Chris Earwood, Cassie M. Lane, Anthony Meluch
The Oncologist 2016; 21:279-280; first published on February 24, 2016; doi:10.1634/theoncologist.2015-0439

贝伐珠单抗联合替莫唑胺用于一线治疗转移性葡萄膜黑色素瘤患者的II期临床试验
Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma
Sophie Piperno-Neumann, Alhassane Diallo, Marie-Christine Etienne-Grimaldi, François-Clément Bidard, Manuel Rodrigues, Corine Plancher, Pascale Mariani, Nathalie Cassoux, Didier Decaudin, Bernard Asselain, Vincent Servois
The Oncologist 2016; 21:281-282; first published on February 24, 2016; doi:10.1634/theoncologist.2015-0501

Breast Cancer

基线心功能筛查在早期乳腺癌治疗中的用途评价
Evaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment
Sandy R. Truong, William T. Barry, Javid J. Moslehi, Emily L. Baker, Erica L. Mayer, Ann H. Partridge
The Oncologist 2016; 21:666-670; first published on April 22, 2016; doi:10.1634/theoncologist.2015-0449

接受芳香化酶抑制剂治疗的绝经后早期乳腺癌女性的患者报告转归与早期停药
Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer
Kunal C. Kadakia, Claire F. Snyder, Kelley M. Kidwell, Nicholas J. Seewald, David A. Flockhart, Todd C. Skaar, Zereunesay Desta, James M. Rae, Julie L. Otte, Janet S. Carpenter, Anna M. Storniolo, Daniel F. Hayes, Vered Stearns, N. Lynn Henry
The Oncologist 2016; 21:539-546; first published on March 23, 2016; doi:10.1634/theoncologist.2015-0349

接受曲妥珠单抗辅助治疗的早期乳腺癌患者发生充血性心力衰竭的风险:Meta分析
Risk of Congestive Heart Failure in Early Breast Cancer Patients Undergoing Adjuvant Treatment With Trastuzumab: A Meta-Analysis
Hui-Dong Long, Yun-En Lin, Juan-Juan Zhang, Wen-Zhao Zhong, Rui-Nian Zheng
The Oncologist 2016; 21:547-554; first published on March 29, 2016; doi:10.1634/theoncologist.2015-0424

荷兰临床实践中曲妥珠单抗辅助治疗过程中的心脏毒性和心脏监测:荷兰东南部乳腺癌联盟研究
Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium
Shanly C. Seferina, Maaike de Boer, M. Wouter Derksen, Franchette van den Berkmortel, Roel J.W. van Kampen, Agnès J. van de Wouw, Manuela Joore, Petronella G.M. Peer, Adri C. Voogd, Vivianne C.G. Tjan-Heijnen
The Oncologist 2016; 21:555-562; first published on March 23, 2016; doi:10.1634/theoncologist.2015-0230

Gastrointestinal Cancer

妊娠期结直肠癌的治疗:细胞毒化疗与靶向治疗的挑战
The Treatment of Colorectal Cancer During Pregnancy: Cytotoxic Chemotherapy and Targeted Therapy Challenges
Jane E. Rogers, Arvind Dasari, Cathy Eng
The Oncologist 2016; 21:563-570; first published on March 21, 2016; doi:10.1634/theoncologist.2015-0362

结直肠癌错配修复状态对辅助化疗治疗决策的影响:基于人群的澳大利亚多中心研究
The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study
Emily Y. He, Nicholas J. Hawkins, Gabriel Mak, Felicia Roncolato, David Goldstein, Winston Liauw, Philip Clingan, Melvin Chin, Robyn L. Ward
The Oncologist 2016; 21:618-625; first published on March 23, 2016; doi:10.1634/theoncologist.2015-0530

Global Health and Cancer

评价careHPV、Cervista人乳头瘤病毒检测及第二代杂交捕获法在诊断新疆维吾尔族妇女宫颈上皮内瘤变2级及以上级别病变中的应用
Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women
Gulixian Tuerxun, Awaguli Yukesaier, Ling Lu, Kailibinuer Aierken, Patiman Mijiti, Yujie Jiang, Axianguli Abulizi, Yuanyuan Zhang, Guzhanuer Abuduxikuer, Guzhalinuer Abulizi, Hua Li
The Oncologist 2016; 21:825-831; first published on June 17, 2016; doi:10.1634/theoncologist.2015-0447

Hepatobiliary

结直肠癌肝转移肝切除术后的早期复发:最佳定义是什么?预测因素又是什么?
Early Recurrence After Hepatectomy for Colorectal Liver Metastases: What Optimal Definition and What Predictive Factors?
Katsunori Imai, Marc-Antoine Allard, Carlos Castro Benitez, Eric Vibert, Antonio Sa Cunha, Daniel Cherqui, Denis Castaing, Henri Bismuth, Hideo Baba, René Adam
The Oncologist 2016; 21:887-894; first published on April 28, 2016; doi:10.1634/theoncologist.2015-0468

美国40年间胆管癌的发病率变化趋势:肝内病变的发病率正在升高
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
Supriya K. Saha, Andrew X. Zhu, Charles S. Fuchs, Gabriel A. Brooks
The Oncologist 2016; 21:594-599; first published on March 21, 2016; doi:10.1634/theoncologist.2015-0446

Lung Cancer

在疾病进展的新时代中重新评估疾病进展:间变性淋巴瘤激酶阳性非小细胞肺癌的一线和二线治疗综述
Re-Evaluating Progression in an Era of Progress: A Review of First- and Second-Line Treatment Options in Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer
Emily H. Castellanos, Leora Horn
The Oncologist 2016; 21:755-761; first published on April 6, 2016; doi:10.1634/theoncologist.2015-0396

综合性基因组分析可鉴别出荧光原位杂交检验未测出的对克唑替尼治疗有应答的ALK重排非小细胞肺癌患者亚组
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
Siraj M. Ali, Thomas Hensing, Alexa B. Schrock, Justin Allen, Eric Sanford, Kyle Gowen, Atul Kulkarni, Jie He, James H. Suh, Doron Lipson, Julia A. Elvin, Roman Yelensky, Zachary Chalmers, Juliann Chmielecki, Nir Peled, Samuel J. Klempner, Kashif Firozvi, Garrett M. Frampton, Julian R. Molina, Smitha Menon, Julie R. Brahmer, Heber MacMahon, Jan Nowak, Sai-Hong Ignatius Ou, Marjorie Zauderer, Marc Ladanyi, Maureen Zakowski, Neil Fischbach, Jeffrey S. Ross, Phil J. Stephens, Vincent A. Miller, Heather Wakelee, Shridar Ganesan, Ravi Salgia
The Oncologist 2016; 21:762-770; first published on May 31, 2016; doi:10.1634/theoncologist.2015-0497

No front page content has been created yet.

 

The Oncologist and the Society for Translational Oncology (STO) partner with the Chinese Society of Clinical Oncology (中国抗癌协会临床肿瘤学协作专业委员会, CSCO) and the CSCO Foundation (中国临床肿瘤学会基金会) on educational initiatives that address critical health and cancer care issues in China. These efforts serve to foster communication between Chinese physicians and other leaders in oncology practice throughout the world.